£75.29

Elsevier Glioblastoma

9780323476607

Price data last checked 152 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 11 months ago.

£75 today · all-time low £74 (Jul 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 579 days • 579 data points (No recent data available)

Historical
Generating forecast...
£76.73 £73.43 £74.15 £74.87 £75.59 £76.31 £77.03 09 June 2024 31 October 2024 25 March 2025 16 August 2025 08 January 2026

Price Distribution

Price distribution over 579 days • 4 price levels

Days at Price
Current Price
7 days 449 days · current 57 days 66 days 0 112 225 337 449 £74 £75 £76 £77 Days at Price

Price Analysis

Most common price: £75 (449 days, 77.5%)

Price range: £74 - £77

Price levels: 4 different prices over 579 days

Description

Clinically focused and designed to provide a to-the-point overview, Glioblastoma, by Drs. Steven Brem and Kalil G. Abdullah, brings you up to date with increased understanding, new treatment protocols, and recent advances in the field. Written by contributing specialists who are global experts in their respective areas, this one-stop reference provides neurosurgeons, medical-and-radiation oncologists, neuro-oncologists, neuropathologists, internal medicine physicians, and researchers with a dependable source of information on current treatment options, tumor recurrence, and patient care. Evidence for current treatment options for de novo and recurrent glioblastoma, indications for local and topical therapies, immunotherapy, gene therapy, nanotherapy, small-molecule inhibition, electric tumor treating field stimulation, and antiangiogenic therapies and the role of Avastin. Recent advances relating to tumor resection, such as stereotactic laser ablation, diffusion tensor imaging, and fluorescent markers. Prognostic molecular and genetic markers and the impact of gene mutations on survival, as well as controversies relating to pseudo-progression. Lessons learned from unsuccessful interventions, as well as the most promising aspects of future glioblastoma research and treatment. Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics
98% match

New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics

£117.69 13 Jan 2026
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)
98% match

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)

Academic Press

£112.19 07 Mar 2026
Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
98% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£147.07 12 Jan 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
97% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

£67.04 12 Jan 2026
Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)
97% match

Precision Molecular Pathology of Glioblastoma (Molecular Pathology Library)

Springer

£76.81 05 Mar 2026
Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies
97% match

Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Springer

£141.86 16 Apr 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
97% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£124.65 30 Mar 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£213.13 06 Feb 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£247.73 05 Feb 2026
Glioblastoma
97% match

Glioblastoma

MDPI AG

£95.47 07 Mar 2026
Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)
97% match

Glioblastoma: Methods and Protocols: 1741 (Methods in Molecular Biology, 1741)

Humana

£5.29 17 Feb 2026
Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America: Volume 32-2 (The Clinics: Surgery, Volume 32-2)
97% match

Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America: Volume 32-2 (The Clinics: Surgery, Volume 32-2)

Elsevier

£89.59 19 Apr 2026
MEDULLOBLASTOMA BOOK (Neuroscience Research Progress)
97% match

MEDULLOBLASTOMA BOOK (Neuroscience Research Progress)

£166.00 10 Mar 2026
New Targeting in The Reversal of Resistant Glioblastomas (Volume 14) (Cancer Sensitizing Agents for Chemotherapy, Volume 14)
97% match

New Targeting in The Reversal of Resistant Glioblastomas (Volume 14) (Cancer Sensitizing Agents for Chemotherapy, Volume 14)

Academic Press

£110.99 01 Mar 2026
Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America: Volume 32-1 (The Clinics: Surgery, Volume 32-1)
97% match

Glioblastoma, Part I: Surgical Management and Adjuncts, An Issue of Neurosurgery Clinics of North America: Volume 32-1 (The Clinics: Surgery, Volume 32-1)

Elsevier

£85.79 10 Apr 2026
Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)
97% match

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

Springer

£142.76 01 Apr 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
97% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£117.56 12 Jan 2026
Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy
97% match

Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy

Springer

£113.09 16 Mar 2026
Humana High-Grade Gliomas: Diagnosis and Treatment Book
97% match

Humana High-Grade Gliomas: Diagnosis and Treatment Book

Humana

£34.33 26 Feb 2026
Neuroblastoma: Clinical and Surgical Management
97% match

Neuroblastoma: Clinical and Surgical Management

Springer

£87.30 11 Mar 2026
High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)
97% match

High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)

Humana

£156.39 09 Mar 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
97% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£147.91 10 Mar 2026
Gliomas: Symptoms, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatments)
97% match

Gliomas: Symptoms, Diagnosis & Treatment Options (Cancer Etiology, Diagnosis and Treatments)

£120.15 13 Jan 2026
Translational Immunotherapy of Brain Tumors
97% match

Translational Immunotherapy of Brain Tumors

Academic Press

£91.00 07 Mar 2026